eLearningworld News

The expectations are now high among researchers that IBM’s Watson can become the bridge to improve treatment of cancer dramatically. “We have to change our whole behavior in looking at tumors. We are missing too much and too often treatment does not work for patients. With Watson, all oncogenes become targets.” says Dr. Ravindra Kolhe, breast and molecular pathologist and director of the Georgia Esoteric & Molecular Labs LLC in the Department of Pathology at the Medical College of Georgia at Augusta University. Basically, Watson provides more comprehensive personalized care to patients, since Watson uses DNA and RNA from a patient’s tumor to gather evidence and analyze data in order to generate knowledge. In about 20 minutes Watson analysing and evaluate solutions for best possible treatment. Source: EurekAlert